Nutra Pharma Corp. (OTC BB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced that Designer Diagnostics, a wholly owned subsidiary of Nutra Pharma, will begin sales of its Test Kits for the rapid identification of NonTuberculosis Mycobacterium (NTM).
